OOIR: Observatory of International Research

Papers

(The H4-Index of Clinical Microbiology Reviews is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Antimicrobial Resistance in ESKAPE Pathogens	893
Coronavirus Disease 2019–COVID-19	651
New β-Lactam–β-Lactamase Inhibitor Combinations	246
Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection	193
Remdesivir against COVID-19 and Other Viral Diseases	168
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders	138
Antifungal Susceptibility Testing: Current Approaches	136
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection	133
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis	120
Performance and Application of 16S rRNA Gene Cycle Sequencing for Routine Identification of Bacteria in the Clinical Microbiology Laboratory	118
Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries: Progress and Challenges in Eight South Asian and Southeast Asian Countries	104
Host-Directed Antiviral Therapy	102
Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria	95
Yersinia pestis: the Natural History of Plague	91
Pathogenesis of Gram-Negative Bacteremia	89
Microsporidiosis in Humans	86
Convalescent Plasma Therapy for COVID-19: State of the Art	86
The Changing Face of the Family Enterobacteriaceae (Order: “ Enterobacterales ”): New Members, Taxonomic Issues, Geographic Expansion, and	80
Viral Respiratory Pathogens and Lung Injury	76
Advances in the Microbiology of Stenotrophomonas maltophilia	75
Evolutionary Pathways and Trajectories in Antibiotic Resistance	72
Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis	70
Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies	67
Burkholderia cepacia Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products	65
Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis	63

Caseum: a Niche for Mycobacterium tuberculosis Drug-Tolerant Persisters	63
Pathogenesis of Respiratory Viral and Fungal Coinfections	62
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes	62
Laboratory Diagnosis of Lyme Borreliosis	59
Intrathecal Antibacterial and Antifungal Therapies	59
SARS-CoV-2 Antiviral Therapy	58
Taenia solium Cysticercosis and Its Impact in Neurological Disease	54
Giardia duodenalis: Biology and Pathogenesis	53
Molecular Epidemiology of Human Cryptosporidiosis in Low- and Middle-Income Countries	53
Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence	47
Environmental, Microbiological, and Immunological Features of Bacterial Biofilms Associated with Implanted Medical Devices	43
Progress and Challenges in the Prevention, Diagnosis, and Management of Cytomegalovirus Infection in Transplantation	43
Staphylococcus lugdunensis: a Skin Commensal with Invasive Pathogenic Potential	41
SARS-CoV-2 and Health Care Worker Protection in Low-Risk Settings: a Review of Modes of Transmission and a Novel Airborne Model Involving Inhalable Particles	41
Human Listeriosis	39